Gilead Reaches $202 Million Settlement Over Payments to Doctors

Gilead Sciences Inc. reached a $202 million settlement with the US to resolve claims that it paid doctors and gave them meals and travel expenses for events to get them to prescribe its drugs.

Federal prosecutors in Manhattan alleged that Gilead conducted programs from January 2011 to November 2017 to promote and increase sales of its drugs to treat the AIDS virus. The events were supposed to be purely educational, with modest meals.

Instead, the US said, the company held the programs at high-end restaurants, allowed practitioners to repeatedly attend events on the same topic and paid for them ...